GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Sale Of Business

INDV (Indivior) Sale Of Business : $0 Mil (TTM As of Mar. 2025)


View and export this data going back to 2014. Start your Free Trial

What is Indivior Sale Of Business?

Indivior's sale of business for the three months ended in Mar. 2025 was $0 Mil. It means Indivior gained $0 Mil from selling business. Indivior's sale of business for the trailing twelve months (TTM) ended in Mar. 2025 was $0 Mil.

Compared with last quarter ($0 Mil in Dec. 2024 ), Indivior gained the same money from selling business in Mar. 2025 ($0 Mil).

Indivior Sale Of Business Historical Data

The historical data trend for Indivior's Sale Of Business can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Indivior Sale Of Business Chart

Indivior Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Sale Of Business
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Indivior Quarterly Data
Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Sale Of Business Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Indivior Sale Of Business Calculation

The amount earned to sell business.


Sale Of Business for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Indivior Sale Of Business Related Terms

Thank you for viewing the detailed overview of Indivior's Sale Of Business provided by GuruFocus.com. Please click on the following links to see related term pages.

Indivior Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Indivior PLC (NAS:INDV) » Definitions » Sale Of Business
Comparable Companies
LSE:APH LSE:AGY LSE:ANCR LSE:EAH LSE:STX LSE:PXS LSE:CEL LSE:N4P LSE:HCM ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA ITCI
Traded in Other Exchanges
INDVl:UK INDV:UK 2IVB:Germany 2IVB:Germany
Address
10710 Midlothian Turnpike, Suite 125, North Chesterfield, Richmond, VA, USA, 23235
Website
https://www.indivior.com
Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs for treatment of substance use disorders and other serious mental illnesses. Its products include, Sublocade, Perseris, Suboxone, Opvee among others. The vast majority of Indivior's revenue is generated in the United States, followed by United Kingdom and the rest of the world.